掃碼下載
BTC $68,565.37 -0.68%
ETH $2,013.14 -0.91%
BNB $627.01 +0.36%
XRP $1.41 +0.22%
SOL $84.03 +0.31%
TRX $0.2765 -0.27%
DOGE $0.0929 -0.80%
ADA $0.2627 -0.04%
BCH $529.44 +2.29%
LINK $8.52 -0.88%
HYPE $29.45 -6.50%
AAVE $108.57 -1.74%
SUI $0.9344 -0.83%
XLM $0.1555 -1.24%
ZEC $238.14 +2.90%
BTC $68,565.37 -0.68%
ETH $2,013.14 -0.91%
BNB $627.01 +0.36%
XRP $1.41 +0.22%
SOL $84.03 +0.31%
TRX $0.2765 -0.27%
DOGE $0.0929 -0.80%
ADA $0.2627 -0.04%
BCH $529.44 +2.29%
LINK $8.52 -0.88%
HYPE $29.45 -6.50%
AAVE $108.57 -1.74%
SUI $0.9344 -0.83%
XLM $0.1555 -1.24%
ZEC $238.14 +2.90%

彭博社:Arthur Hayes 近期重金投資某人類壽命延長公司,過去 1 年定期接受幹細胞靜脈輸注治療

2025-08-21 09:43:07
收藏

ChainCatcher 消息,据彭博社報導,BitMEX 聯合創始人 Arthur Hayes 正將投資目光轉向人類壽命延長領域,其近期重金投資了一家在墨西哥和曼谷設有診所的幹細胞企業,並加入其董事會。

過去一年他定期乘機前往接受靜脈輸注治療,直言"希望儘可能健康地延長壽命"。儘管因品牌重塑暫未透露公司名稱,但他強調:這是未來趨勢------越來越多國家正放寬幹細胞使用法規。

app_icon
ChainCatcher 與創新者共建Web3世界